150 related articles for article (PubMed ID: 698890)
1. Specificity of tumor-associated antibodies in sera of patients with uveal melanoma.
Brownstein S; Phillips TM; Lewis MG
Can J Ophthalmol; 1978 Jul; 13(3):190-3. PubMed ID: 698890
[TBL] [Abstract][Full Text] [Related]
2. Immunological studies in patients with malignant melanoma of the uvea.
Brownstein S; Sheikh KM; Lewis MG
Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536
[TBL] [Abstract][Full Text] [Related]
3. Immunofluorescent detection of antibodies to ocular melanomas.
Wong IG; Oskvig RM
Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249
[No Abstract] [Full Text] [Related]
4. MELANOCYTES, MELANOCYTIC NEVI, AND MELANOCYTOMAS.
ZIMMERMAN LE
Invest Ophthalmol; 1965 Feb; 4():11-41. PubMed ID: 14271285
[No Abstract] [Full Text] [Related]
5. Tumor-associated antibodies to ocular and cutaneous malignant melanomas: negative interaction with normal choroidal melanocytes.
Federman JL; Lewis MG; Clark WH
J Natl Cancer Inst; 1974 Feb; 52(2):587-9. PubMed ID: 4593142
[No Abstract] [Full Text] [Related]
6. Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
Cochran AJ; Foulds WS; Damato BE; Trope GE; Morrison L; Lee WR
Br J Ophthalmol; 1985 Mar; 69(3):171-6. PubMed ID: 3884037
[TBL] [Abstract][Full Text] [Related]
7. Uveitis in melanomatous swine: lack of evidence for humoral immune melanocyte destruction.
Feeney-Burns L; Alspaugh M; Burns RP; Gao CL
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):551-60. PubMed ID: 3980171
[TBL] [Abstract][Full Text] [Related]
8. Contractile protein antigens in the cells of malignant melanoma of the choroid and their diagnostic significance.
Rahi AH; Garner A; Malaty AH
Br J Ophthalmol; 1978 Jun; 62(6):394-401. PubMed ID: 666989
[TBL] [Abstract][Full Text] [Related]
9. Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression.
Lentz KJ; Burns RP; Loeffler K; Feeney-Burns L; Berkelhammer J; Hook RR
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1063-9. PubMed ID: 6874271
[TBL] [Abstract][Full Text] [Related]
10. Melanocyte mutation in halo naevus and malignant melanoma?
Bennett C; Copeman PW
Br J Dermatol; 1979 Apr; 100(4):423-6. PubMed ID: 378250
[TBL] [Abstract][Full Text] [Related]
11. Cellular resistance to human uveal melanoma. An in vitro study.
Hart DR; Reznikov M; Hughes LE
Arch Ophthalmol; 1968 Jun; 79(6):748-54. PubMed ID: 5652266
[No Abstract] [Full Text] [Related]
12. Inhibition of macrophage migration by choroidal malignant melanoma-associated antigens in patients with unveal melanoma.
Manor RS; Livni E; Joshua H; Ben-Sira I
Invest Ophthalmol Vis Sci; 1978 Jul; 17(7):684-7. PubMed ID: 352988
[TBL] [Abstract][Full Text] [Related]
13. Relationship of iris nevi to malignant melanoma of the uvea.
Michelson JB; Shields JA
Am J Ophthalmol; 1977 May; 83(5):694-6. PubMed ID: 868968
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen. Its role in the evaluation of intraocular malignant tumors.
Michelson JB; Felberg NT; Shields JA
Arch Ophthalmol; 1976 Mar; 94(3):414-6. PubMed ID: 1267924
[TBL] [Abstract][Full Text] [Related]
17. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
Maeda K; Maeda K; Jimbow K
J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
[TBL] [Abstract][Full Text] [Related]
18. Uveal findings in patients with cutaneous melanoma.
Albert DM; Searl SS; Forget B; Lavin PT; Kirkwood J; Nordlund JJ
Am J Ophthalmol; 1983 Apr; 95(4):474-9. PubMed ID: 6837689
[TBL] [Abstract][Full Text] [Related]
19. The halo naevus and malignant melanoma.
Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
[No Abstract] [Full Text] [Related]
20. Tumor-associated antibodies in the serum of patients with ocular melanoma. IV. Correction for smooth muscle antibodies.
Felberg NT; Donoso LA; Federman JL
Ophthalmology; 1980 Jun; 87(6):529-33. PubMed ID: 6997787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
